Tongue Cancer Completed Phase Trials for DB00317 (Gefitinib)

IndicationStatusPhase
DBCOND0029843 (Tongue Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00068497Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerTreatment